These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 22435671)

  • 1. Reduction of BDNF expression in Fmr1 knockout mice worsens cognitive deficits but improves hyperactivity and sensorimotor deficits.
    Uutela M; Lindholm J; Louhivuori V; Wei H; Louhivuori LM; Pertovaara A; Akerman K; Castrén E; Castrén ML
    Genes Brain Behav; 2012 Jul; 11(5):513-23. PubMed ID: 22435671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BDNF and TrkB in neuronal differentiation of Fmr1-knockout mouse.
    Louhivuori V; Vicario A; Uutela M; Rantamäki T; Louhivuori LM; Castrén E; Tongiorgi E; Akerman KE; Castrén ML
    Neurobiol Dis; 2011 Feb; 41(2):469-80. PubMed ID: 21047554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins.
    Spencer CM; Serysheva E; Yuva-Paylor LA; Oostra BA; Nelson DL; Paylor R
    Hum Mol Genet; 2006 Jun; 15(12):1984-94. PubMed ID: 16675531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Male and female Fmr1 knockout mice on C57 albino background exhibit spatial learning and memory impairments.
    Baker KB; Wray SP; Ritter R; Mason S; Lanthorn TH; Savelieva KV
    Genes Brain Behav; 2010 Aug; 9(6):562-74. PubMed ID: 20398059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fmr1 knockout mice are impaired in a leverpress escape/avoidance task.
    Brennan FX; Albeck DS; Paylor R
    Genes Brain Behav; 2006 Aug; 5(6):467-71. PubMed ID: 16923151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BDNF in fragile X syndrome.
    Castrén ML; Castrén E
    Neuropharmacology; 2014 Jan; 76 Pt C():729-36. PubMed ID: 23727436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic changes in calbindin D28K immunoreactivity in the hippocampus of Fmr1 knockout mice.
    Real MA; Simón MP; Heredia R; de Diego Y; Guirado S
    J Comp Neurol; 2011 Sep; 519(13):2622-36. PubMed ID: 21491426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice.
    Frankland PW; Wang Y; Rosner B; Shimizu T; Balleine BW; Dykens EM; Ornitz EM; Silva AJ
    Mol Psychiatry; 2004 Apr; 9(4):417-25. PubMed ID: 14981523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of FMR1 deletion in a subpopulation of post-mitotic neurons in mouse cortex and hippocampus.
    Amiri A; Sanchez-Ortiz E; Cho W; Birnbaum SG; Xu J; McKay RM; Parada LF
    Autism Res; 2014 Feb; 7(1):60-71. PubMed ID: 24408886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-derived neurotrophic factor expression is increased in the hippocampus of 5-HT(2C) receptor knockout mice.
    Hill RA; Murray SS; Halley PG; Binder MD; Martin SJ; van den Buuse M
    Hippocampus; 2011 Apr; 21(4):434-45. PubMed ID: 20087884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
    Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA
    Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AFQ056, a new mGluR5 antagonist for treatment of fragile X syndrome.
    Levenga J; Hayashi S; de Vrij FM; Koekkoek SK; van der Linde HC; Nieuwenhuizen I; Song C; Buijsen RA; Pop AS; Gomezmancilla B; Nelson DL; Willemsen R; Gasparini F; Oostra BA
    Neurobiol Dis; 2011 Jun; 42(3):311-7. PubMed ID: 21316452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mice with reduced brain-derived neurotrophic factor expression show decreased choline acetyltransferase activity, but regular brain monoamine levels and unaltered emotional behavior.
    Chourbaji S; Hellweg R; Brandis D; Zörner B; Zacher C; Lang UE; Henn FA; Hörtnagl H; Gass P
    Brain Res Mol Brain Res; 2004 Feb; 121(1-2):28-36. PubMed ID: 14969734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of Fmr1 in parvalbumin-expressing neurons results in dysregulated translation and selective behavioral deficits associated with fragile X syndrome.
    Kalinowska M; van der Lei MB; Kitiashvili M; Mamcarz M; Oliveira MM; Longo F; Klann E
    Mol Autism; 2022 Jun; 13(1):29. PubMed ID: 35768828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragile X mental retardation protein is required for chemically-induced long-term potentiation of the hippocampus in adult mice.
    Shang Y; Wang H; Mercaldo V; Li X; Chen T; Zhuo M
    J Neurochem; 2009 Nov; 111(3):635-46. PubMed ID: 19659572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective cognitive deficits and reduced hippocampal brain-derived neurotrophic factor mRNA expression in small-conductance calcium-activated K+ channel deficient mice.
    Jacobsen JP; Redrobe JP; Hansen HH; Petersen S; Bond CT; Adelman JP; Mikkelsen JD; Mirza NR
    Neuroscience; 2009 Sep; 163(1):73-81. PubMed ID: 19482064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term behavioral and NMDA receptor effects of young-adult corticosterone treatment in BDNF heterozygous mice.
    Klug M; Hill RA; Choy KH; Kyrios M; Hannan AJ; van den Buuse M
    Neurobiol Dis; 2012 Jun; 46(3):722-31. PubMed ID: 22426399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of the performance of individuals with fragile X syndrome and Fmr1 knockout mice on Hebb-Williams mazes.
    MacLeod LS; Kogan CS; Collin CA; Berry-Kravis E; Messier C; Gandhi R
    Genes Brain Behav; 2010 Feb; 9(1):53-64. PubMed ID: 19796132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation.
    Qin M; Kang J; Smith CB
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15758-63. PubMed ID: 12427968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral Phenotype of Fmr1 Knock-Out Mice during Active Phase in an Altered Light/Dark Cycle.
    Saré RM; Levine M; Smith CB
    eNeuro; 2016; 3(2):. PubMed ID: 27294193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.